From MedPage Today:
- Predicting Death in Advanced Cancer. Late-occurring signs of declining neurocognitive function proved to be highly specific and highly likely markers of impending death in patients with advanced-stage cancer.
- JAK-3 Drug Effective in RA, but Safe? The oral selective JAK-3 inhibitor decernotinib was associated with significant improvements in symptom relief for rheumatoid arthritis in a multicenter phase IIa trial, but dose-related safety signals emerged during the study.
- Study Questions Value of Long Resuscitation in Drowned Kids. Negative outcomes were seen in drowned children who couldn’t be resuscitated within 30 minutes.
- Older Patients Benefit From ICD Placement. Implantable cardioverter-defibrillators (ICDs) improve survival even in the oldest, sickest heart failure patients, but advancing age appears to lessen this survival advantage.
